A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: ‘bile ductular carcinoma’
暂无分享,去创建一个
O. Matsui | T. Fujii | Yasunori Sato | Y. Nakanuma | K. Harada | M. Sasaki | Y. Zen | H. Minato | K. Kozaka | Y. Sato | S. Sawada | Hiroshi Minato | Osamu Matsui
[1] T Nakajima,et al. A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: histologic classification and modes of spreading. , 1988, Human pathology.
[2] Stanley R. Hamilton,et al. Pathology and genetics of tumours of the digestive system , 2000 .
[3] S. Kitano,et al. Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment , 1998, The British journal of surgery.
[4] M. Tsuneyoshi,et al. The significance of stromal desmoplasia in intrahepatic cholangiocarcinoma: a special reference of 'scirrhous-type' and 'nonscirrhous-type' growth. , 1999, The American journal of surgical pathology.
[5] Y. Nakanuma,et al. Expression of vimentin in proliferating and damaged bile ductules and interlobular bile ducts in nonneoplastic hepatobiliary diseases. , 1992, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[6] T. Terada,et al. Vascular supply in adenomatous hyperplasia of the liver and hepatocellular carcinoma: a morphometric study. , 1992, Human pathology.
[7] J. H. Lim,et al. Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. , 2003, AJR. American journal of roentgenology.
[8] K. Sugimachi,et al. Coexpression of neural cell adhesion molecules and bcl‐2 in intrahepatic cholangiocarcinoma originated from viral hepatitis: Relationship to atypical reactive bile ductule , 2002, Pathology international.
[9] Y. Maehara,et al. Decreased expression of osteopontin is related to tumor aggressiveness and clinical outcome of intrahepatic cholangiocarcinoma , 2004, Liver international : official journal of the International Association for the Study of the Liver.
[10] J. Lau,et al. Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications. , 1996, The American journal of pathology.
[11] Y. N. Park,et al. Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype. , 2004, Journal of hepatology.
[12] Y. Nakanuma,et al. Immunohistochemical study on bile ductular proliferation in various hepatobiliary diseases. , 2008, Liver.
[13] M. Kojiro,et al. Clinicopathologic study on cholangiolocellular carcinoma. , 2001, Oncology reports.
[14] P. Bedossa,et al. An algorithm for the grading of activity in chronic hepatitis C , 1996, Hepatology.
[15] J. Hirabayashi,et al. Expression of endogenous galectin-1 and galectin-3 in intrahepatic cholangiocarcinoma. , 2001, Human pathology.
[16] M. Kojiro,et al. Histologic growth pattern of hepatocellular carcinoma: relationship to orcein (hepatitis B surface antigen)-positive cells in cancer tissue. , 1982, Human pathology.
[17] E. Van Cutsem,et al. Primary liver tumour of intermediate (hepatocyte-bile duct cell) phenotype: a progenitor cell tumour? , 2008, Liver.
[18] K. Tsuneyama,et al. Intrahepatic cholangiocarcinoma in cirrhosis presents granulocyte and granulocyte-macrophage colony-stimulating factor. , 2003, Human pathology.
[19] J. Lau,et al. Hepatocellular carcinoma expressing both hepatocellular and biliary markers also expresses cytokeratin 14, a marker of bipotential progenitor cells. , 1999, Journal of hepatology.
[20] J. Belghiti,et al. [Primary malignant tumors of the liver]. , 1989, Il Giornale di chirurgia.
[21] S. Fan,et al. Intrahepatic Cholangiocarcinoma , 1997, World Journal of Surgery.
[22] O. Matsui,et al. Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material. , 2002, Radiology.
[23] A. West,et al. Nomenclature of the finer branches of the biliary tree: Canals, ductules, and ductular reactions in human livers , 2004, Hepatology.
[24] V. Desmet,et al. Neuroendocrine features of reactive bile ductules in cholestatic liver disease. , 1990, The American journal of pathology.
[25] V. Desmet,et al. Ductular reaction and its diagnostic significance. , 1998, Seminars in diagnostic pathology.
[26] S. Locarnini. Molecular virology of hepatitis B virus. , 2004, Seminars in liver disease.
[27] R. Figueroa Barrios. [Chronic hepatitis]. , 1995, Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru.
[28] S. Mukerjee,et al. CHOLANGIOLOCELLULAR CARCINOMA OF THE LIVER. , 1964, Journal of the Indian Medical Association.
[29] Motoko Sasaki,et al. Anatomic and molecular pathology of intrahepatic cholangiocarcinoma. , 2003, Journal of hepato-biliary-pancreatic surgery.
[30] J. Neuberger,et al. Characterization and isolation of ductular cells coexpressing neural cell adhesion molecule and Bcl-2 from primary cholangiopathies and ductal plate malformations. , 2000, The American journal of pathology.
[31] T. Yoshikawa,et al. Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma? , 1998, Journal of surgical oncology.
[32] T. Terada,et al. Histologic growth patterns of metastatic carcinomas of the liver. , 1996, Japanese journal of clinical oncology.
[33] Brian P. Mulhall,et al. Nonalcoholic steatohepatitis , 2004, Current treatment options in gastroenterology.
[34] Y. Nakanuma,et al. Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply , 1997, Microscopy research and technique.
[35] M. Kojiro,et al. Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma. A study of 57 autopsy‐proven cases , 1977, Cancer.